SCHEMBL8306273

SCHEMBL8306273

CCN1c2ncccc2C(=O)N(C)c2ccc(O)nc21

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
BRD4 O60885 14/20 0.41
CYP1A2 P05177 1/20 0.39
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
MPI P34949 1/20 0.35
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8299587 0.86 CYP3A4 (0.52) CYP3A4CYP2C9CYP2C19BRD4ALDH1A1
SCHEMBL8889357 0.85 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8301130 0.83 BRD4 (0.41) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8298361 0.83 CYP3A4 (0.41) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8300415 0.83 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8301155 0.81 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8701364 0.80 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8545648 0.80 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8547631 0.80 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8301122 0.80 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19BRD4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
US-5620974-A ENZYME INHIBITOR, TREATS ACQUIRED IMMUNE DEFICIENCY SYNDROME(AIDS) BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1997-04-15 US disclosed
US-5366972-A 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1994-11-22 US disclosed
EP-0429987-A2 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1991-06-05 EP disclosed